Migraine Diagnosis, Treatment and Market Report by DelveInsight

Migraine Diagnosis, Treatment and Market Report by DelveInsight

The Migraine market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted migraine symptoms market size from 2018 to 2030 segmented by seven major markets. The report also covers current Migraine symptoms treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.


Migraine Overview

Migraine is a neurological condition that can cause multiple symptoms. It is frequently characterized by intense, debilitating headaches. A migraine is a moderate or severe headache felt as a throbbing pain on one side of the head. Symptoms may include nausea, vomiting, difficulty speaking, numbness or tingling, and sensitivity to light and sound. Migraines often run in families and affect all ages.


Download free sample copy- https://www.delveinsight.com/sample-request/migraine-market


List of regions covered in the report

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


List of Migraine companies involved in the report

  • Lundbeck Seattle BioPharmaceutical
  • Eli Lilly and Company
  • Amgen/Novartis
  • Teva Pharmaceuticals
  • Allergan
  • Biohaven Pharmaceuticals
  • Dr. Reddy’s Labs
  • Eli Lilly and Company
  • Allergan
  • Biohaven Pharmaceuticals
  • AbbVie
  • Impel NeuroPharma
  • Zosano Pharma
  • Axsome Therapeutics
  • And many others


Migraine Cause

The exact cause of migraines is unknown, but they are thought to be the result of abnormal brain activity temporarily affecting nerve signals, chemicals, and blood vessels in the brain. Many possible migraine triggers have been suggested, including hormonal, emotional, physical, dietary, environmental, and medicinal factors. These triggers vary among individuals, but a diary may help keep track of consistent triggers.


Migraine Diagnosis

There is currently no cure for migraines, although several treatments are available to help ease the symptoms. Most people find that sleeping or lying in a darkened room is the best thing to do when having a migraine attack. Over-the-counter medications are effective for some people with mild to moderate migraines. The main ingredients in pain-relieving medications are ibuprofen, aspirin, acetaminophen, naproxen, and caffeine.


Migraine Treatment

It covers the details of conventional and current medical therapies and diagnosis available in the migraine market to treat the condition. It also provides country-wise treatment guidelines and algorithms across the United States, Europe, and Japan.

The DelveInsight Migraine market report gives a thorough understanding of MIGRAINE symptoms by including disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides MIGRAINE symptoms of treatment algorithms and treatment guidelines for Migraine symptoms in the US, Europe, and Japan.


Migraine Drug Chapters

The drug chapter segment of the Migraine report encloses the detailed analysis of migraine marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps understand the Migraine clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug, and the latest news and press releases.


Migraine Emerging Drug

Zavegepant (Biohaven Pharmaceuticals) is a third-generation, high affinity, selective, and structurally unique, small molecule CGRP receptor antagonist from Biohaven’s Nojection Migraine Platform and the only CGRP receptor antagonist in clinical development with both intranasal and oral formulations. The efficacy and safety profile of intranasal Zavegepant for the acute treatment of migraine, as compared to placebo, was shown in a randomized controlled Phase II/III dose-ranging trial with a total of over 1,000 patients who received Zavegepant.


Migraine Market Report Scope

  • The report covers the descriptive overview of migraine, explaining its causes, signs and symptoms, pathophysiology, and currently available therapies
  • Comprehensive insight has been provided into the Migraine epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for migraine is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of the Migraine market; historical and forecasted, is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies by understanding trends shaping and driving the global Migraine market


Download free sample copy- https://www.delveinsight.com/sample-request/migraine-market


Table of Content

1. Key Insights

2. Report Introduction

3. Migraine Market Overview at a Glance

4. Executive Summary of Migraine

5. Disease Background and Overview

6. Treatment

7. Epidemiology and Patient Population

8. Organizations contributing toward Migraine

9. Patient Journey

10. Case Reports

11. Marketed Therapies

12. Emerging Therapies

13. Migraine: Seven Major Market Analysis

14. Market Outlook

15. Market Access

16. Market Drivers

17. Market Barriers

18. Unmet Needs

19. SWOT Analysis

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight


Migraine Market Report Highlights

  • In the coming years, the Migraine market is set to change due to the rising awareness of the disease and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Migraine R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
  • Major players are involved in developing therapies for MIGRAINE. The launch of emerging therapies will significantly impact the Migraine market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for migraine
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities


About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/